NewAmsterdam Pharma Co N.V Capital Expenditures (CapEx) Growth & History (NAMS)

NewAmsterdam Pharma Co N.V's capital expenditures (capex) was $246,000 for fiscal 2025.

View full NewAmsterdam Pharma Co N.V company overview

NewAmsterdam Pharma Co N.V annual capital expenditures (capex) history

NewAmsterdam Pharma Co N.V annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20252025-12-31$246,000−$426,000−63.39%
20242024-12-31$672,000$648,000+2700.00%
20232023-12-31$24,000−$197,000−89.14%
20222022-12-31$221,000$197,000+820.83%
20212021-12-31$24,000

NewAmsterdam Pharma Co N.V capital expenditures (capex) trends

Between the periods ended 2021-12-31 and 2025-12-31, NewAmsterdam Pharma Co N.V's capital expenditures (capex) increased from $24,000 to $246,000, a change of $222,000. The latest reported quarter, Q2 2026, shows $80,000.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review NewAmsterdam Pharma Co N.V source filings ↗

Community posts

It’s quiet here.

No posts about NAMS yet. Start the conversation.

Write the first post